Rheumatology – Bones, Joints, Muscle and Autoimmunity

1 week ago

Myositis as an adverse event of immune checkpoint blockade for cancer therapy

Myositis associated with cancer therapy with immune checkpoint inhibitors. Something to be aware of when getting referral from oncology colleagues.

#myositis #oncology #cancer #ICIs

Immune checkpoint inhibitors (ICIs) can successfully treat cancer, but their use can be hindered by serious immune-related adverse events. We report six patients receiving ICIs who presented with de novo myositis. ... See more

View on facebook

3 weeks ago

Fifteen percent of osteoporosis patients who take 'drug holidays' suffer bone fractures

Challenging the practice of “drug holidays” for bisphosphonates.

#osteoporosis #fractures #bone

A new study has found that 15.4 percent of patients who take so-called 'drug holidays' from osteoporosis drugs called bisphosphonates experienced bone fractures. During a six-year follow-up period, ... See more

View on facebook

3 weeks ago

Efficiency of dose reduction strategy of etanercept in patients with axial spondyloarthritis.

Increasing the interval between doses and dose reduction for biologic is possible in axial SpA maintaining good control. This can help reduce the cost.

#SpA #etanercept

OBJECTIVES: To evaluate the efficacy of different tapering or discontinuation strategies of etanercept in a cohort of axial spondyloarthritis from South China.

View on facebook

3 weeks ago

Adalimumab Clears Nail Disease in Psoriatic Arthritis

Adalimumab beneficial for nail disease in psoriasis. Nail parameters often overlooked.

#adalimumab #psoriasis #bsr18

Nail involvement often overlooked

View on facebook

3 weeks ago

Clinical Challenges: Combination Therapy for Osteoporosis

Combination therapy for osteoporosis! Still no fracture data.

#osteoporosis

Studies show a benefit in high-risk patients

View on facebook

« ‹ 1 of 2 › »